| Ytd | 4.41% | |
| 1y | 30.84% |
| Open | 599.99 | Prev Close | 599.69 | Low | 594.81 | High | 606.21 | Mkt Cap | 224.83B |
| Vol | 0.00 | Avg Vol | 2.32M | EPS | 23.16 | P/E | 26.12 | Forward P/E | 21.59 |
| Beta | 0.85 | Short Ratio | 2.52 | Inst. Own | 93.83% | Dividend | 1.88 | Div Yield | 0.32 |
| Ex Div Date | 09-15 | Earning | 07-23 | 50-d Avg | 519.80 | 200-d Avg | 532.02 | 1yr Est | 631.42 |
Thermo Fisher Scientific is eyeing a 15%-20% increase in its customer base in India over the next f
Thermo Fisher Scientific Inc. TMO raised its 2026 outlook after second-quarter earnings and revenues
Examine the evolution of Thermo Fisher's (TMO) overseas revenue trends and their effects on Wall Str
Argent Capital Management LLC trimmed its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:
TMO is expanding bioproduction, AI tools and clinical data capabilities, but execution will be key a
Amundi raised its holdings in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 22.4% in the fi
Jefferies just named five U.S. dividend stocks to its exclusive Global Best Ideas list, and with the
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, will
Dan Loeb reduced his Danaher stake and exited Thermo Fisher in Q1 2026 as the billionaire investor t
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific today announced the global launch of Therm
Thermo Fisher Scientific NYSE: TMO reported stronger-than-expected second-quarter 2026 results and r
Thermo Fisher Scientific Inc. (TMO) Q2 2026 Earnings Call Transcript
Thermo Fisher Scientific Inc. (NYSE:TMO) on Thursday reported second-quarter adjusted earnings of $
Stocks slide Thursday as Brent crude breaks $100 and the 10-year yield hits an 18-month high, while
Thermo Fisher beats Q2 earnings and revenue estimates as organic growth and stronger customer activi
Although the revenue and EPS for Thermo Fisher (TMO) give a sense of how its business performed in t
U.S. stocks were down as Dow Jones fell 450 points on Thursday. Lockheed Martin (LMT) shares rose 11
Thermo Fisher Scientific (TMO) came out with quarterly earnings of $6.03 per share, beating the Zack
Earnings back in focus on Thursday, with a Benzinga-selected watchlist including Intel and Lockheed
Companies Reporting Before The Bell • Altisource Portfolio (NASDAQ:ASPS) is estimated to report quar
Thermo Fisher Scientific beat Wall Street estimates for second-quarter profit and revenue on Thursda
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serv
Acumen Wealth Advisors LLC cut its holdings in Thermo Fisher Scientific Inc. (NYSE: TMO) by 14.7% in
ImmuPharma PLC (AIM:IMM, FRA:25I), the drug discovery company, has appointed Thermo Fisher Scientifi
Andra AP fonden raised its holdings in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 1,411.
Earnings season takes center stage next week with options markets pricing in big post-results moves.
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Arcturus partners with Thermo Fisher to support Phase 3 development and potential commercialization
Strategic manufacturing agreement includes Phase 3 clinical supply and commercial manufacturing righ
Daniel Loeb's Third Point added Meta, Alphabet, Broadcom, and semiconductor names while sharply
Jenny Van Leeuwen Harrington of Gilman Hill Asset Management named Thermo Fisher Scientific Inc. (TM
Apple, Amazon and TSMC are among the largest companies to deliver earnings "triple plays" th
Benzinga analysts changed outlook on top names. For all rating changes, incl upgrades/downgrades, se
Major M&A deals this week: Corebridge Financial acquires Equitable Holdings for $22 billion, Abb
Hedge fund billionaire Daniel Loeb reshuffled positions at Third Point LLC in the fourth quarter, ad
Shares of QXO rose 4.4% to close at $27.07 on Friday; Thermo Fisher slipped 1% to $504.82; and Apoll
Earnings season is in full-swing with reports this week from several Mag Seven names, big tech compa
Today's "Final Trades" segment focused on UnitedHealth, Thermo Fisher Scientific, iShare
Year to date, Thermo Fisher fell about 21.03%, both underperforming the iShares U.S. Healthcare ETF,
Loeb's Third Point LLC restructured their portfolio in last quarter of 2024. They decreased stak